Viimeisin päivitys :
19/11/2024
Infostab
Luettelo yhdisteistä
Yhteenveto-luettelot
Etsi yhteensopivuutta
Y-sivuston yhteensopivuustaulukko
Viitteet
tutkimus Joukkueet
valistab
ilmoitus
Liitännät
sponsorit
Tekijät
Käyttöohje
Uutiskirje
Hydrocortisone
Kemiallinen rakenne
Viitteet : Hydrocortisone
tyyppi
julkaisu
909
Lehti
Chong G, Decarie D, Ensom M.H.H.
Stability of hydrocortisone in extemporaneously compounded suspensions.
J Informed Pharmacother 2003 ; 13: 100-110.
2538
Lehti
Fawcett JP, Boulton DW, Jiang R, Woods DJ.
Stability of hydrocortisone oral suspensions prepared from tablets and powder.
Ann Pharmacotherapy 1995 ;29:987-990.
2835
Lehti
Das Gupta V.
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Int J Pharm Compound 2007 ; 11, 3: 259-261.
3755
Lehti
Bourget P, Amin A, Vidal F, Pieyre M, Dosso E.O, Beauvais R, Loeuillet R.
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition.
Int J Pharm Compound 2014 ; 18, 5: 427-431.
3810
Lehti
Geiger C M, Sorenson B, Whaley P.
Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF.
Int J Pharm Compound 2015 ; 19, 5 : 420-427.
3811
Lehti
Nahata Milap C.
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures.
Int J Pharm Compound 2015 ; 19, 5 : 428-431.
4063
Lehti
Manchanda A, Laracy M, Savji T, Bogner R.
Stability of an Alcohol-free, Dye-free Hydrocortisone (2mg/mL) Compounded Oral Suspension.
Int J Pharm Compound 2018 ;22,1:66-75
4198
Lehti
Uriel M, Gomez-Rincon C, Marro D.
Stability of regularly prescribed oral liquids formulated with SyrSpend® SF.
Pharmazie 2018 73;196-201
4530
Lehti
Pramar Y, Mandal T, Bostanian L, Kader C, Morris T, Graves R.
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt.
Int J Pharm Compound 2021 ;25,5:431-439
Mentions Légales
